In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 27, No. 3 ( 2007-03), p. 614-620
Abstract:
We show increased plasma levels of the homeostatic chemokines in CCL19 and CCL21 in clinical and experimental atherosclerosis. By promoting inflammatory responses in T-cells and by inducing a matrix degrading, prothrombotic, and inflammatory phenotype in macrophages, we suggest that these chemokines could contribute to atherogenesis and plaque destabilization.
Type of Medium:
Online Resource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/01.ATV.0000255581.38523.7c
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2007
detail.hit.zdb_id:
1494427-3
Permalink